BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9498743)

  • 1. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95.
    McLeod JD; Walker LS; Patel YI; Boulougouris G; Sansom DM
    J Immunol; 1998 Mar; 160(5):2072-9. PubMed ID: 9498743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
    Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of superantigen and lipopolysaccharide on induction of CD80 through apoptosis of human monocytes.
    Takahashi M; Takahashi M; Shinohara F; Takada H; Rikiishi H
    Infect Immun; 2001 Jun; 69(6):3652-7. PubMed ID: 11349026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.
    Schafer PH; Wang L; Wadsworth SA; Davis JE; Siekierka JJ
    J Immunol; 1999 Jan; 162(2):659-68. PubMed ID: 9916683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
    Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
    Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
    Miethke T; Vabulas R; Bittlingmaier R; Heeg K; Wagner H
    Eur J Immunol; 1996 Jul; 26(7):1459-67. PubMed ID: 8766547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
    Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
    J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis.
    Daniel PT; Kroidl A; Cayeux S; Bargou R; Blankenstein T; Dörken B
    J Immunol; 1997 Oct; 159(8):3808-15. PubMed ID: 9378968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
    Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
    Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes.
    Hornung F; Zheng L; Lenardo MJ
    J Immunol; 1997 Oct; 159(8):3816-22. PubMed ID: 9378969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.